McKesson Corporation vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? McKesson Corporation trades at $937.1 (market cap $108.46B), while Direxion Daily Semiconductor Bear 3X Shares trades at $34.44 (market cap $1.96B). The key difference: McKesson Corporation is far larger — about 55.3× Direxion Daily Semiconductor Bear 3X Shares's market cap, and McKesson Corporation pays a 0.4% dividend while Direxion Daily Semiconductor Bear 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| MCK | SOXS | |
|---|---|---|
Market Cap | $108.46B | $1.96B |
Volume | 712,607 | 113,512,541 |
Sector | Health | Leveraged / Inverse |
52-Week High | $995.69 | $988.00 |
52-Week Low | $725.17 | $29.62 |
Typical Hold Time | 74 Days | 11 Days |
Enterprise Value | $115.00B | — |
Dividend Yield | 0.4% | — |
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $937.98, up 3.04% with strong technical momentum and bullish analyst sentiment. The stock shows consistent earnings beats with Q2 2026 EPS of $9.93 exceeding expectations of $9.56. Recent positive developments include the CVS Health partnership extension through 2032 and raised full-year guidance. Revenue growth remains robust at $359.05 billion for 2025, though net margins are thin at 1.12%.
The outlook remains positive with 81% analyst buy ratings and a $956.43 consensus target. Key risks include margin pressure from drug pricing dynamics and policy uncertainty. Strong cash flow generation ($6.09B operating cash flow) supports the dividend and growth initiatives, while technical indicators show the stock testing resistance near $938.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $34.53, up 12.68% with a bearish technical signal. The fund provides inverse leveraged exposure to semiconductor stocks, making it highly volatile and suitable for short-term tactical trades rather than long-term investment. Recent performance reflects semiconductor sector weakness, with technical indicators showing mixed signals but overall bearish momentum.
The outlook remains challenging as SOXS faces structural headwinds from persistent AI hardware demand and semiconductor industry strength. Investment opportunities exist for tactical bearish bets during sector pullbacks, but risks include high volatility, decay from daily rebalancing, and potential for rapid losses if semiconductor stocks rebound. The fund is best suited for experienced traders with short-term horizons.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →